Compare Duke Energy Corp (DUK) vs Recursion Pharmaceuticals Inc (RXRX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Duke Energy Corp vs Recursion Pharmaceuticals Inc — how do they compare? Duke Energy Corp trades at $123.08 (market cap $96.05B), while Recursion Pharmaceuticals Inc trades at $3.38 (market cap $1.81B). The key difference: Duke Energy Corp is far larger — about 53.1× Recursion Pharmaceuticals Inc's market cap, and Duke Energy Corp pays a 3.52% dividend while Recursion Pharmaceuticals Inc pays none. Which is the better fit depends on your goals.
| DUK | RXRX | |
|---|---|---|
Market Cap | $96.05B | $1.81B |
Sector | Utilities | Health |
52-Week High | $133.46 | $6.79 |
52-Week Low | $113.99 | $2.84 |
Enterprise Value | $188.56B | $1.33B |
Dividend Yield | 3.52% | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Duke Energy Corp
Duke Energy is one of the largest U.S. utilities, with regulated utilities in the Carolinas, Indiana, Florida, Ohio, and Kentucky that deliver electricity to nearly 8 million customers. Its natural gas utilities serve more than 1.5 million customers. Duke operates in three major segments: electric utilities and infrastructure
Read more on DUK →About Recursion Pharmaceuticals Inc
Recursion Pharmaceuticals, Inc. is a clinical-stage biotechnology company leveraging artificial intelligence (AI) and machine learning to industrialize drug discovery. The company's unique approach combines one of the world's largest biological and chemical datasets with automated wet-lab and computational systems to map human biology and identify potential therapeutic candidates across a range of diseases, including oncology and rare diseases. Recursion aims to accelerate the traditionally slow and expensive process of drug development.
Read more on RXRX →
